Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Mitocholine Ltd | 16 |
| 2 | BASF SE | 5 |
| 3 | Teva Pharmaceutical Industries Ltd | 4 |
| 4 | Azurity Pharmaceuticals Inc | 2 |
| 5 | Honeywell Aerospace Inc | 2 |
| 6 | Laboratoire Aguettant SAS | 2 |
| 7 | Amcor PLC | 1 |
| 8 | Anhui Medical University | 1 |
| 9 | GSK PLC | 1 |
| 10 | Hikma Pharmaceuticals PLC | 1 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 60 |
| 2 | A61P | Therapeutic activity (drug indications) | 35 |
| 3 | A23L | Foods and beverages (general) | 20 |
| 4 | A23V | Foods, foodstuffs - indexing scheme | 18 |
| 5 | C08L | Polymer compositions (blends) | 14 |
| 6 | A61L | Sterilising / disinfecting materials | 13 |
| 7 | C08B | 12 | |
| 8 | A61Q | Cosmetics, personal care | 8 |
| 9 | C08F | Polymers from C=C unsaturated bonds | 8 |
| 10 | C08H | 7 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Cationic oil-in-water emulsions | 2019 | GSK PLC | 31 |
| GELMA POLYMER COMPOSITIONS AND USES THEREOF | 2022 | 11 | |
| Cosmetic compounding agent, cosmetic and method for producing same | 2021 | 7 | |
| GELMA POLYMER COMPOSITIONS AND USES THEREOF | 2023 | 4 | |
| COSMETIC INGREDIENT, COSMETIC, AND PRODUCTION METHOD FOR COSMETIC | 2020 | 7 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 1 |
| 2020 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Frank Mußhoff | University of Bonn | 7 |
| 2 | Uta Kuepper | University of Bonn | 7 |
| 3 | Burkhard Madea | University of Bonn | 7 |
| 4 | Frank Herbstreit | Essen University Hospital | 2 |
| 5 | Hiroto Fudeta | Tohoku University | 1 |
| 6 | Shoichi Obara | Tohoku University | 1 |
| 7 | Marc A. LeBeau | Federal Bureau of Investigation | 1 |
| 8 | Isamu Yasuda | Tohoku Rosai Hospital | 1 |
| 9 | Charles Quenzer | Federal Bureau of Investigation | 1 |
| 10 | Klaus Altland | Universität Hamburg | 1 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| An analytical strategy for quaternary ammonium neuromuscular blocking agents in a forensic setting using LC-MS/MS on a tandem quadrupole/time-of-flight instrument | 2006 | 39 | Anesthesia and Sedative Agents |
| Drug storage: a cautionary note. | 1986 | 1 | Pharmaceutical studies and practices |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and chemical name of succinylmonocholine?
Which organizations hold the most patents related to succinylmonocholine?
What are the main technology classifications for succinylmonocholine patents?
How has patent activity for succinylmonocholine changed in recent years?
What research has been published on succinylmonocholine and what are the main research areas?